Stratec SE
XETRA:SBS
Stratec SE
XETRA:SBS
Price:
43.7 EUR
0.81%
Market Closed
Updated:
May 16, 2024
EV/IC
Enterprise Value to IC
Enterprise Value to IC
1.5
Current
3
Median
2
Industry
Lower
than median
Lower
than industry value
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
EV/IC
=1.5
Enterprise Value
/
602.4m
Invested Capital
415.3m
All Countries
| Market Cap | EV/IC | ||||
|---|---|---|---|---|---|
| DE |
|
Stratec SE
XETRA:SBS
|
531.2m EUR | 1.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.9B USD | 3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.7B USD | 12.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126.5B USD | 3.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.6B USD | 1.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.4B USD | 3.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.6B USD | 1.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.7B EUR | 1.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
54.3B USD | 7.6 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
377.4B CNY | 13.5 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.4B USD | 15.4 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/IC
N/A
2-Years Forward
EV/IC
N/A
3-Years Forward
EV/IC
N/A
You don't have any saved screeners yet
